Using SCA1 knock-in mice, we discovered that BG inflammation indeed plays a deleterious role in SCA that can be thwarted by a c-Jun N-terminal kinase (JNK) inhibitory drug that prevents c-Jun activation. This evidence concerns the gene JUN and autosomal dominant cerebellar ataxia.